ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,341Medicare Part D Prescriptions Filled, Including Refills

Rank: 543 out of 2061

$446K Total Retail Price of All Prescriptions

Rank: 804 out of 2061

358 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,333 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 484 431 1 3
LISINOPRIL 400 326 2 2
METOPROLOL TARTRATE 376 361 3 7
AMLODIPINE BESYLATE 373 353 4 4
SIMVASTATIN 335 284 5 1
FUROSEMIDE 232 206 6 6
PRAVASTATIN SODIUM 231 203 7 14
HYDROCHLOROTHIAZIDE 197 179 8 12
OMEPRAZOLE 193 182 9 5
METFORMIN HCL 180 150 10 9
GLIMEPIRIDE 170 135 11 33
WARFARIN SODIUM 167 163 12 11
GABAPENTIN 166 134 13 15
ATORVASTATIN CALCIUM 155 137 14 8
SERTRALINE HCL 145 127 15 21
HYDROCODONE-ACETAMINOPHEN 138 118 S3 16 10
ATENOLOL 128 118 17 13
METOPROLOL SUCCINATE 123 109 18 19
VITAMIN D2 116 116 19 146
DIOVAN 112 112 20 41
SYNTHROID 110 96 21 58
ALLOPURINOL 105 100 22 28
FLUTICASONE PROPIONATE 102 80 23 43
DONEPEZIL HCL 98 98 24 24
ISOSORBIDE MONONITRATE ER 95 92 25 42
CLONIDINE HCL 83 83 26 52
PROAIR HFA 83 63 26 40
POTASSIUM CHLORIDE 83 65 26 16
TRAMADOL HCL 82 70 29 18
GLYBURIDE 78 75 R 30 60
ZETIA 75 75 31 68
LOSARTAN POTASSIUM 67 67 32 17
MIRTAZAPINE 66 60 33 46
ENALAPRIL MALEATE 65 61 34 75
CLOPIDOGREL 65 49 34 29
LANTUS 62 58 36 48
AMITRIPTYLINE HCL 55 54 R 37 89
JANUVIA 55 55 37 51
ALENDRONATE SODIUM 54 47 39 25
CRESTOR 52 47 40 31
DIGOXIN 51 47 41 56
RANITIDINE HCL 51 32 41 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.